[et_pb_section fb_built=“1″ admin_label=“Header“ _builder_version=“4.27.4″ _module_preset=“2e264158-b54d-4d7f-8146-8c8b7ca64cef“ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/header-Publications.jpeg“ background_position=“top_center“ background_last_edited=“on|phone“ background_image_phone=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Mobile-Header-6.png“ background_enable_image_phone=“on“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“7px|30px||30px|false|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.5″ _module_preset=“default“ header_font=“|700||on|||||“ header_font_size=“80px“ custom_margin=“11px||||false|false“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.27.5″ _module_preset=“default“ background_color=“#e1e2ed“ custom_margin=“||||false|false“ custom_padding=“||37px||false|false“ global_colors_info=“{}“][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.5″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=“4.27.5″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n
This page provides access to the results of the ASCERTAIN project. In line with our commitment to transparency and open science, all project outcomes will be made publicly available here as they are developed.<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.27.5″ _module_preset=“default“ background_color=“RGBA(255,255,255,0)“ custom_margin=“||||false|false“ custom_padding=“||37px||false|false“ global_colors_info=“{}“][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.0″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=“4.27.7″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n
PRICING METHODS FOR INNOVATIVE HEALTH TECHNOLOGIES<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n COST-EFFECTIVENESS AND BUDGET IMPACT MODELS FOR INNOVATIVE HEALTH TECHNOLOGIES (IHT)<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n REIMBURSEMENT FOR INNOVATIVE HEALTH TECHNOLOGIES<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Leaflet on price regulation for medicines.<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Leaflet on QALY.<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Leaflet on uncertain data.<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Leaflet on regulatory diagnostics.<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.8″ _module_preset=“default“ hover_enabled=“0″ global_colors_info=“{}“ sticky_enabled=“0″]<\/p>\n Leaflet on cost-effectiveness models.<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Klicken Sie hier, um die Projektbrosch\u00fcre zu lesen<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.5″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=“rowmitklapptext“ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n ACCESS2MEDS FRAMEWORK V3<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=“rowmitklapptext“ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Newsletter 01 – September 2023<\/a><\/strong><\/p>\n Newsletter 02 – March 2024<\/a><\/strong><\/p>\n Newsletter 03 – September 2024<\/a><\/strong><\/p>\n Newsletter 04 – March 2025<\/a><\/strong><\/p>\n Newsletter 05 – October 2025<\/a><\/strong><\/p>\n Newsletter 06 – April 2026<\/strong><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=“off|off|off“ module_class=“rowmitklapptext“ _builder_version=“4.25.1″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.5″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=“rowmitklapptext“ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=“rowmitklapptext“ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.6″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n Press Release 01<\/a><\/strong><\/p>\n Press Release 02<\/a><\/strong><\/p>\n Press Release 03<\/strong><\/a><\/p>\n Press Release 04<\/strong><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_class=“rowmitklapptext“ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ header_2_font=“|600||on|||||“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ module_id=“Kontakt“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#86B8BD“ custom_margin=“||||false|false“ custom_padding=“16px||75px||false|false“ box_shadow_style=“preset7″ box_shadow_horizontal=“0px“ box_shadow_vertical=“-274px“ box_shadow_color=“#FFFFFF“ global_module=“910″ saved_tabs=“all“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ header_font=“Poppins semibold|||on|||||“ header_font_size=“36px“ custom_margin=“14px||23px||false|false“ custom_margin_tablet=““ custom_margin_phone=“||30px||false|false“ custom_margin_last_edited=“on|phone“ header_font_size_phone=“24px“ global_colors_info=“{}“]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_font=“Poppins regular||||||||“ text_text_color=“#393C84″ text_font_size=“24px“ text_line_height=“1.33em“ module_alignment=“right“ custom_margin=“||0px||false|false“ text_font_size_tablet=““ text_font_size_phone=“18px“ text_font_size_last_edited=“on|phone“ global_colors_info=“{}“]<\/p>\n Kontaktieren Sie uns gerne bei Fragen oder Anmerkungen \u2013 wir melden uns schnellstm\u00f6glich bei Ihnen zur\u00fcck! <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_3,1_3,1_3″ use_custom_gutter=“on“ module_class=“tablet-three-cols“ _builder_version=“4.20.2″ _module_preset=“default“ max_width_tablet=“980px“ max_width_phone=“500px“ max_width_last_edited=“on|phone“ custom_padding=“0px|30px|0px|30px|false|true“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|phone“ custom_css_main_element_tablet=“display:flex;“ custom_css_main_element_phone=“display:flex; flex-direction:column;“][et_pb_column type=“1_3″ _builder_version=“4.20.2″ _module_preset=“be0fba28-f74a-4ba0-9a8d-9cd30aca805d“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|tablet“ custom_css_main_element_tablet=“margin-bottom:0;“ custom_css_main_element_phone=“margin-bottom:20px;“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png“ title_text=“Carin_Uyl-de-Groot“ _builder_version=“4.20.2″ _module_preset=“a348f9e0-d57b-4c22-b522-c52b784fe57f“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_text_color=“#FFFFFF“ link_text_color=“#FFFFFF“ global_colors_info=“{}“]<\/p>\n F\u00fcr forschungsbezogene Fragen:<\/p>\n Carin Uyl-de Groot<\/strong> Erasmus Universit\u00e4t Rotterdam [\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.20.2″ _module_preset=“be0fba28-f74a-4ba0-9a8d-9cd30aca805d“ background_color=“#393C84″ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|phone“ custom_css_main_element_tablet=“margin-bottom:0;“ custom_css_main_element_phone=“margin-bottom:20px;“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png“ title_text=“Marcel-Langone“ align=“center“ _builder_version=“4.20.2″ _module_preset=“a348f9e0-d57b-4c22-b522-c52b784fe57f“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_text_color=“#FFFFFF“ link_text_color=“#FFFFFF“ global_colors_info=“{}“]<\/p>\n F\u00fcr allgemeine Fragen zum Projekt:<\/p>\n Marcel Langone Marques<\/strong>LEAFLET<\/h2>\n
BROSCH\u00dcRE<\/h2>\n
VIDEOS<\/h2>\n
\n
ACCESS2MEDS FRAMEWORK<\/h2>\n
NEWSLETTER<\/h2>\n
POSTER<\/h2>\n
\n
DOI: https:\/\/doi.org\/10.1016\/j.annonc.2024.08.159<\/a><\/li>\nWEBINARE<\/h2>\n
\n
<\/span><\/li>\nPressemitteilungen<\/h2>\n
Sonstige <\/h2>\n
\n
Kontakt<\/h1>\n
Projektkoordinatorin<\/p>\n
uyl@eshpm.eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n
Projektleiter<\/p>\n